RUSSO, ANTONIO
 Distribuzione geografica
Continente #
EU - Europa 2.762
NA - Nord America 1.434
AS - Asia 1.210
SA - Sud America 180
Continente sconosciuto - Info sul continente non disponibili 63
AF - Africa 22
OC - Oceania 1
Totale 5.672
Nazione #
RU - Federazione Russa 2.056
US - Stati Uniti d'America 1.366
SG - Singapore 411
IT - Italia 259
CN - Cina 252
IE - Irlanda 215
HK - Hong Kong 158
VN - Vietnam 150
BR - Brasile 135
KR - Corea 72
GB - Regno Unito 55
JP - Giappone 48
DE - Germania 46
IN - India 46
FR - Francia 39
CA - Canada 29
AR - Argentina 18
BD - Bangladesh 17
GR - Grecia 12
NL - Olanda 12
PL - Polonia 12
ID - Indonesia 11
FI - Finlandia 10
MX - Messico 10
IQ - Iraq 9
TR - Turchia 9
AT - Austria 8
EC - Ecuador 8
ES - Italia 8
CO - Colombia 7
CR - Costa Rica 6
SE - Svezia 6
AZ - Azerbaigian 5
PK - Pakistan 5
RS - Serbia 5
UA - Ucraina 5
ZA - Sudafrica 5
GP - Guadalupe 4
JM - Giamaica 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UZ - Uzbekistan 4
CH - Svizzera 3
EG - Egitto 3
PE - Perù 3
PR - Porto Rico 3
PY - Paraguay 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
CD - Congo 2
DK - Danimarca 2
HN - Honduras 2
IL - Israele 2
IR - Iran 2
LT - Lituania 2
MA - Marocco 2
NI - Nicaragua 2
RO - Romania 2
AL - Albania 1
AU - Australia 1
BE - Belgio 1
BO - Bolivia 1
CL - Cile 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MY - Malesia 1
MZ - Mozambico 1
NG - Nigeria 1
PA - Panama 1
PT - Portogallo 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
VE - Venezuela 1
Totale 5.610
Città #
Moscow 767
Dublin 215
San Jose 197
Singapore 194
Ashburn 182
Santa Clara 165
Hong Kong 157
Council Bluffs 82
Seoul 72
Hefei 67
Ho Chi Minh City 49
Naples 44
Hanoi 39
New York 37
The Dalles 36
Bengaluru 29
Chandler 29
Milan 26
Los Angeles 25
Caserta 23
Dallas 20
Beijing 19
Memphis 19
Princeton 18
Roxbury 18
Cambridge 16
Washington 16
Bremen 15
São Paulo 14
Da Nang 11
Miano 11
Munich 11
Jacksonville 10
Amsterdam 9
London 9
Orem 9
Phoenix 9
Toronto 9
Warsaw 9
Chennai 8
North Bergen 8
Tokyo 8
Boston 7
Florence 7
Frankfurt am Main 7
Giugliano in Campania 7
Nuremberg 7
Brooklyn 6
Jinan 6
Porto Alegre 6
Rome 6
San José 6
Baku 5
Belgrade 5
Boardman 5
Brasília 5
Bắc Ninh 5
Guastalla 5
Haiphong 5
Helsinki 5
Istanbul 5
Kingston 5
Lappeenranta 5
Paris 5
Redwood City 5
Stockholm 5
Tianjin 5
Atlanta 4
Biên Hòa 4
Brescia 4
Campinas 4
Can Tho 4
Des Moines 4
Hillsboro 4
Johannesburg 4
Lucca 4
Quito 4
Tashkent 4
Vienna 4
Wilmington 4
Ariano Irpino 3
Aversa 3
Buenos Aires 3
Charlotte 3
Dhaka 3
Guangzhou 3
Hangzhou 3
Juiz de Fora 3
Lima 3
Miami 3
Padua 3
Pointe-à-Pitre 3
Ribeirão Preto 3
Rio Claro 3
Rio de Janeiro 3
Abbeville 2
Akron 2
Ankara 2
Asunción 2
Baghdad 2
Totale 2.958
Nome #
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 191
Abacavir hypersensivity reaction (HSR), associated to baseline false negative HLAB5701 screening, in antiretroviral treatment naive HIV-1 patient. 171
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 170
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 164
Cardiovascular system in COVID-19: Simply a viewer or a leading actor? 162
Delirium and Psychiatric Sequelae Associated to SARS-CoV-2 in Asymptomatic Patients With Psychiatric History and Mild Cognitive Impairment as Risk Factors: Three Case Reports 152
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 151
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study 148
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 144
Directly acting antiviral-based treatment for hcv-infected persons who inject drugs: A multicenter real-life study 144
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 143
An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta-analysis 143
Epidemiological and etiological variations in hepatocellular carcinoma 142
Clinical Characterization of the Three Waves of COVID-19 Occurring in Southern Italy: Results of a Multicenter Cohort Study 137
Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: A meta-analysis 137
Different Clinical Outcomes of COVID-19 in Two Healthcare Workers Vaccinated with BNT162b2 Vaccine, Infected with the Same Viral Variant but with Different Predisposing Conditions for the Progression of the Disease 132
Inappropriateness of Antibiotic Prescribing in Medical, Surgical and Intensive Care Units: Results of a Multicentre Observational Study 131
Efficacy and Tollerability of INI-Based 2-Drug Regimen in Virosuppressed Persons Living with HIV: A Systematic Review and Meta-Analysis 131
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis 131
Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study 130
Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data 127
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial 127
Innovative procedures for micro-elimination of HCV infection in persons who use drugs 127
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study 125
Impact of an education‐based antimicrobial stewardship program on the appropriateness of antibiotic prescribing: Results of a multicenter observational study 125
Blood donor serological screening for SARS-CoV-2 as a tool to estimate the prevalence of asymptomatic infection in a low-intermediate endemic area of southern Italy after the first wave of the pandemic 123
Assessment and Comparison of Two Serological Approaches for the Surveillance of Health Workers Exposed to SARS-CoV-2 121
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 121
Standard versus high dose of rifampicin in the treatment of pulmonary tuberculosis: a systematic review and meta-analysis 120
Clinical features of patients with home isolation SARS-COV-2 infection: A multicenter retrospective study in southern Italy 114
Hbv/hdv co‐infection: Epidemiological and clinical changes, recent knowledge and future challenges 113
Burden, risk assessment, surveillance and management of SARS-CoV-2 infection in health workers: A scoping review 111
Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine 110
Current status of laboratory diagnosis for covid-19: A narrative review 105
Evaluation of Lipid Profile and Intima Media Thickness in Antiretroviral-Experienced HIV-Infected Patients Treated with Protease Inhibitor-Based Regimens versus Protease Inhibitor-Sparing Regimens 104
RISK OF FAILURE IN DUAL THERAPY VERSUS TRIPLE THERAPY IN NAÏVE HIV-PATIENTS: A META-ANALYSIS 104
Pre-existing chronic kidney disease (CDK) was not associated with a severe clinical outcome of hospitalized COVID-19: results of a case-control study in Southern Italy 102
Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review 102
Hepatitis C virus (HCV) micro-elimination in the hospital setting: The results of the HCV Caserta hospital project 101
Prevalence of occult HBV infection in Western countries 99
The SpO2/FiO2 Ratio Combined with Prognostic Scores for Pneumonia and COVID-19 Increases Their Accuracy in Predicting Mortality of COVID-19 Patients 95
Reazione di ipersensibilità ad abacavir associata a test HLAB5701 falsamente negativo al basale, in paziente HIV naive al trattamento antiretrovirale. 93
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 82
Prognostic Value of Transaminases and Bilirubin Levels at Admission to Hospital on Disease Progression and Mortality in Patients with COVID-19—An Observational Retrospective Study 80
null 37
Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort 22
Clinical Evolution in COVID-19: Predictive Hematobiochemical Values, Monoclonal Antibody Effectiveness, and Long COVID Prognostic Factors 19
null 9
Totale 5.672
Categoria #
all - tutte 19.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.963


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 0 0 25 0 9 2 1 4 4 38
2022/2023335 23 6 6 6 45 28 2 10 178 6 11 14
2023/2024307 19 10 36 30 97 46 4 6 7 6 7 39
2024/2025784 1 11 8 31 125 112 118 61 150 47 76 44
2025/20263.548 190 255 177 120 336 1.904 181 106 107 69 56 47
2026/2027500 12 38 194 256 0 0 0 0 0 0 0 0
Totale 5.672